In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Myriad invests in Crescendo; takes option to buy company; option exercised

Executive Summary

Myriad Genetics Inc. has made a $25mm debt investment in fellow molecular diagnostics company Crescendo Bioscience Inc., and has signed a definitive three-year option agreement to acquire the company.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Concluded
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register